Cargando…
Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
BACKGROUND: Treatment with immune checkpoint inhibitors (ICIs) has been associated with an increased rate of cardiac events. There are limited data on the risk factors that predict cardiac events in patients treated with ICIs. Therefore, we created a machine learning (ML) model to predict cardiac ev...
Autores principales: | Heilbroner, Samuel Peter, Few, Reed, Neilan, Tomas G, Mueller, Judith, Chalwa, Jitesh, Charest, Francois, Suryadevara, Somasekhar, Kratt, Christine, Gomez-Caminero, Andres, Dreyfus, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491414/ https://www.ncbi.nlm.nih.gov/pubmed/34607896 http://dx.doi.org/10.1136/jitc-2021-002545 |
Ejemplares similares
-
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study
por: Mandala, Mario, et al.
Publicado: (2021) -
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
por: Zubiri, Leyre, et al.
Publicado: (2021) -
Increased rates of immunosuppressive treatment and hospitalization after checkpoint inhibitor therapy in cancer patients with autoimmune disease
por: Bender, David Andrew, et al.
Publicado: (2020) -
Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
por: Drobni, Zsofia Dora, et al.
Publicado: (2023) -
Pericardial disease in patients treated with immune checkpoint inhibitors
por: Gong, Jingyi, et al.
Publicado: (2021)